Brittney Jean Schultz

Brittney Schultz practices at M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota.

Brittney Schultz's NPI, 1710305180, was assigned on April 2, 2014. Brittney Schultz graduated from University of Minnesota Medical School in 2014. Brittney Schultz holds Minnesota license 61357.

Brittney Schultz's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis, at 909 Fulton Street Southeast, Minneapolis, MN 55455. The practice phone is (612) 676-5500.

Brittney Schultz's primary practice is M Health Fairview Clinics and Surgery Center - Minneapolis in Minneapolis, Minnesota. Brittney Schultz is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Brittney Schultz to 3 more group practices and clinics and 3 medical groups, each named with a free account. Brittney Schultz's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Brittney Schultz practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Brittney Schultz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Brittney Schultz is licensed in Minnesota.

CMS data shows 1,248 Medicare services from Brittney Schultz across 13 procedure codes in 2024, for 282 Medicare patients. Medicare paid $59,836 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Brittney Schultz in 2024. The largest group is 65 to 74, with 129 patients. 65% of them have high cholesterol, and 61% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brittney Schultz's median patient age at 59, with 64% women.

In 2024, Brittney Schultz wrote 1,378 Medicare Part D claims for 318 patients. 78% of them were for generic drugs. CMS names the drug for 1,181 of them, across 27 drugs with 11 or more claims each, at $1,098,137 in total drug cost. In 2023, CMS named 848 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Brittney Schultz for performance year 2024, reported as part of a group. Brittney Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brittney Schultz as offering telehealth. CMS counts 183 procedures of skin biopsy by Brittney Schultz, more than 83% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Brittney Schultz, published from 2018 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Pemphigus, Skin and Amphiregulin. Brittney Schultz has published most often in Dermatitis. Brittney Schultz's most frequent co-authors are Bruce Robert Blazar, MD, Rita Khodosh, MD, PhD and Margaret L. MacMillan, MD.

CMS Open Payments shows 63 general payments to Brittney Schultz from 5 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 89% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $36,067.

Brittney Schultz graduated from University of Minnesota Medical School in 2014.